
Nianxiang Zou
Examiner (ID: 1845, Phone: (571)272-2850 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1671, 1648 |
| Total Applications | 872 |
| Issued Applications | 513 |
| Pending Applications | 81 |
| Abandoned Applications | 303 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18341904
[patent_doc_number] => 11639378
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-02
[patent_title] => Polyomavirus neutralizing antibodies
[patent_app_type] => utility
[patent_app_number] => 17/502910
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 33429
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17502910
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/502910 | Polyomavirus neutralizing antibodies | Oct 14, 2021 | Issued |
Array
(
[id] => 18860307
[patent_doc_number] => 20230414741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => METHOD AND COMPOSITON FOR TREATING CANCER USING A VACCINE
[patent_app_type] => utility
[patent_app_number] => 18/248861
[patent_app_country] => US
[patent_app_date] => 2021-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14879
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248861
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/248861 | METHOD AND COMPOSITON FOR TREATING CANCER USING A VACCINE | Oct 11, 2021 | Pending |
Array
(
[id] => 17368366
[patent_doc_number] => 20220023418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => FUCOSYLLACTOSE AS BREAST MILK IDENTICAL NON-DIGESTIBLE OLIGOSACCHARIDE WITH NEW FUNCTIONAL BENEFIT
[patent_app_type] => utility
[patent_app_number] => 17/493647
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4787
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17493647
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/493647 | FUCOSYLLACTOSE AS BREAST MILK IDENTICAL NON-DIGESTIBLE OLIGOSACCHARIDE WITH NEW FUNCTIONAL BENEFIT | Oct 3, 2021 | Abandoned |
Array
(
[id] => 18512532
[patent_doc_number] => 20230228736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => IN VITRO HBV CORE PROTEIN ASSAY
[patent_app_type] => utility
[patent_app_number] => 17/492238
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17492238
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/492238 | IN VITRO HBV CORE PROTEIN ASSAY | Sep 30, 2021 | Abandoned |
Array
(
[id] => 20993372
[patent_doc_number] => 12741992
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-09-22
[patent_title] => Bacterial pilus protein complex FIMGT-DSF stabilized protein complexes for producing filamentous phages
[patent_app_type] => utility
[patent_app_number] => 18/028245
[patent_app_country] => US
[patent_app_date] => 2021-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 4
[patent_no_of_words] => 6205
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18028245
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/028245 | BACTERIAL PILUS PROTEIN COMPLEX FIMGT-DSF STABILIZED PROTEIN COMPLEXES FOR PRODUCING FILAMENTOUS PHAGES | Sep 27, 2021 | Pending |
Array
(
[id] => 17482642
[patent_doc_number] => 20220090146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => ATTB CELL LINE, TRANSGENIC CELL LINES DERIVED THEREFROM, AND METHODS OF MAKING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/484476
[patent_app_country] => US
[patent_app_date] => 2021-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15148
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17484476
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/484476 | Attb cell line, transgenic cell lines derived therefrom, and methods of making the same | Sep 23, 2021 | Issued |
Array
(
[id] => 17480658
[patent_doc_number] => 20220088162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => Heterologous Prime Boost Vaccine
[patent_app_type] => utility
[patent_app_number] => 17/474240
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -121
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17474240
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/474240 | Heterologous Prime Boost Vaccine | Sep 13, 2021 | Pending |
Array
(
[id] => 17399907
[patent_doc_number] => 20220041997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => Method for rescuing influenza virus and composition therefor
[patent_app_type] => utility
[patent_app_number] => 17/471709
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7131
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17471709
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/471709 | Method for rescuing influenza virus and composition therefor | Sep 9, 2021 | Abandoned |
Array
(
[id] => 18732578
[patent_doc_number] => 11801298
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-31
[patent_title] => MERS-CoV vaccine
[patent_app_type] => utility
[patent_app_number] => 17/472003
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 59
[patent_no_of_words] => 24511
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472003
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/472003 | MERS-CoV vaccine | Sep 9, 2021 | Issued |
Array
(
[id] => 20344199
[patent_doc_number] => 12467926
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-11
[patent_title] => Method for determining immune competence against severe acute respiratory syndrome coronavirus 2
[patent_app_type] => utility
[patent_app_number] => 17/470283
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 0
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17470283
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/470283 | Method for determining immune competence against severe acute respiratory syndrome coronavirus 2 | Sep 8, 2021 | Issued |
Array
(
[id] => 17482713
[patent_doc_number] => 20220090217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => BIOMARKERS AND USES THEREOF IN THE TREATMENT OF CHRONIC HBV INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/463824
[patent_app_country] => US
[patent_app_date] => 2021-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25881
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17463824
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/463824 | BIOMARKERS AND USES THEREOF IN THE TREATMENT OF CHRONIC HBV INFECTION | Aug 31, 2021 | Abandoned |
Array
(
[id] => 17300911
[patent_doc_number] => 20210396750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => SYSTEM AND METHOD FOR DIGITAL REMOTE PRIMARY, SECONDARY, AND TERTIARY COLOR CALIBRATION VIA SMART DEVICE IN ANALYSIS OF MEDICAL TEST RESULTS
[patent_app_type] => utility
[patent_app_number] => 17/463618
[patent_app_country] => US
[patent_app_date] => 2021-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 230
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17463618
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/463618 | SYSTEM AND METHOD FOR DIGITAL REMOTE PRIMARY, SECONDARY, AND TERTIARY COLOR CALIBRATION VIA SMART DEVICE IN ANALYSIS OF MEDICAL TEST RESULTS | Aug 31, 2021 | Abandoned |
Array
(
[id] => 18771224
[patent_doc_number] => 20230366040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => RAPID AND LOW-COST NUCLEIC ACID DETECTION USING TRANSLATION-BASED SEQUENCE VERIFICATION ASSAYS
[patent_app_type] => utility
[patent_app_number] => 18/021719
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18021719
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/021719 | RAPID AND LOW-COST NUCLEIC ACID DETECTION USING TRANSLATION-BASED SEQUENCE VERIFICATION ASSAYS | Aug 25, 2021 | Pending |
Array
(
[id] => 17548142
[patent_doc_number] => 20220119483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/410453
[patent_app_country] => US
[patent_app_date] => 2021-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17410453
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/410453 | MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF | Aug 23, 2021 | Abandoned |
Array
(
[id] => 17274745
[patent_doc_number] => 20210380943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => GENERATING HPV ANTIGEN-SPECIFIC T CELLS FROM A NAIVE T CELL POPULATION
[patent_app_type] => utility
[patent_app_number] => 17/404105
[patent_app_country] => US
[patent_app_date] => 2021-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17404105
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/404105 | Generating HPV antigen-specific T cells from a naive T cell population | Aug 16, 2021 | Issued |
Array
(
[id] => 20729113
[patent_doc_number] => 12636357
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-26
[patent_title] => Vaccine composition for preventing tuberculosis comprising chorismate mutase
[patent_app_type] => utility
[patent_app_number] => 18/021258
[patent_app_country] => US
[patent_app_date] => 2021-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 65
[patent_figures_cnt] => 65
[patent_no_of_words] => 2980
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18021258
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/021258 | Vaccine composition for preventing tuberculosis comprising chorismate mutase | Aug 11, 2021 | Issued |
Array
(
[id] => 17503525
[patent_doc_number] => 20220096627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/399821
[patent_app_country] => US
[patent_app_date] => 2021-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17399821
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/399821 | COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS | Aug 10, 2021 | Abandoned |
Array
(
[id] => 17399994
[patent_doc_number] => 20220042084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => SPATIAL SEQUENCING
[patent_app_type] => utility
[patent_app_number] => 17/396579
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46186
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17396579
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/396579 | Spatial sequencing | Aug 5, 2021 | Issued |
Array
(
[id] => 18740852
[patent_doc_number] => 20230349829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => METHODS OF DIAGNOSTICS
[patent_app_type] => utility
[patent_app_number] => 18/016932
[patent_app_country] => US
[patent_app_date] => 2021-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18016932
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/016932 | METHODS OF DIAGNOSTICS | Aug 2, 2021 | Pending |
Array
(
[id] => 18649918
[patent_doc_number] => 20230295746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => A DETECTION METHOD
[patent_app_type] => utility
[patent_app_number] => 18/018523
[patent_app_country] => US
[patent_app_date] => 2021-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18499
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018523
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/018523 | A DETECTION METHOD | Jul 26, 2021 | Pending |